Several EU countries reverse suspension of Oxford-AstraZeneca COVID jab after EU issues fresh advice saying it is ‘safe and effective’
In a SkyNews report, anyone with headache for more than four days after Oxford-AstraZeneca jab should seek medical attention, says a UK regulator.
The report further states that ‘significant’ vaccine supply issue causes by delayed shipment from India and 1.7 million doses needing to be re-tested to check stability
The University of Oxford says vaccines are more effective against the Brazil variant than previously thought.
COMMENTS